Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Ulcerative Colitis: 2024 American Gastroenterological Association Evidence Synthesis

By sjmartinez • October 20, 2024

Ananthakrishnan AN, Murad MH, Scott FI, Agrawal M, Haydek JP, Limketkai BN, Loftus EV Jr, Singh S. Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Ulcerative Colitis: 2024 American Gastroenterological Association Evidence Synthesis. Gastroenterology. 2024 Oct 18:S0016-5085(24)05480-5. doi: 10.1053/j.gastro.2024.07.046. Epub ahead of print. PMID: 39425738.

Tags: Biologics, Comparative Effectiveness, Digestive Diseases, guidelines, Inflammatory Bowel Diseases, Positioning, Publications

The Epidemiology of Young-Onset Barrett’s Esophagus in the United States: A National Population-Based Study Using the TriNetX Database

Vasireddy AR, Chandar AK, Maravillas MA, Perez JA, Algarin Perneth SL, Kolb JM, Leggett CL, Katzka DA, Iyer PG, Gaddam S, Kamboj AK. The Epidemiology[...]

Correction to: Abdominal Symptom Improvement During Clinical Trials of Tenapanor in Patients With Irritable Bowel Syndrome With Constipation: A Post Hoc Analysis

Lembo AJ, Chey WD, Harris LA, Frazier R, Brenner DM, Chang L, Lacy BE, Edelstein S, Yang Y, Zhao S, Rosenbaum DP. Correction to: Abdominal[...]

An IL-17-DUOX2 axis controls gastrointestinal colonization by Candida albicans

Kakade P, Burgueno JF, Sircaik S, Ponde NO, Li J, Ene IV, Kim J, Liang SH, Yunker R, Dey I, Akiba Y, Vaishnava S, Kaunitz[...]